# Effect of Talampanel (an AMPA Receptor Blocker) on Brain Activity

> **NCT00057460** · PHASE2 · COMPLETED · sponsor: **National Institute of Neurological Disorders and Stroke (NINDS)** · enrollment: 25 (—)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Talampanel

## Key facts

- **NCT ID:** NCT00057460
- **Lead sponsor:** National Institute of Neurological Disorders and Stroke (NINDS)
- **Sponsor class:** NIH
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-04
- **Primary completion:** —
- **Final completion:** 2006-05
- **Target enrollment:** 25 (—)
- **Last updated:** 2008-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00057460

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00057460, "Effect of Talampanel (an AMPA Receptor Blocker) on Brain Activity". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00057460. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*